Walleye Capital’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4
Closed -$49 4553
2025
Q4
$49 Sell
4
-123
-97% -$1.32K ﹤0.01% 4449
2025
Q3
$1.12K Sell
127
-11,279
-99% -$87.7K ﹤0.01% 4371
2025
Q2
$72.8K Buy
+11,406
New +$65.3K ﹤0.01% 3912
2025
Q1
Sell
-5,993
Closed -$49.6K 4475
2024
Q4
$57.3K Sell
5,993
-18,265
-75% -$168K ﹤0.01% 4327
2024
Q3
$203K Sell
24,258
-72,349
-75% -$658K ﹤0.01% 3999
2024
Q2
$659K Buy
96,607
+65,607
+212% +$282K 0.01% 3257
2024
Q1
$78.4K Sell
31,000
-238,690
-89% -$538K ﹤0.01% 4512
2023
Q4
$647K Buy
269,690
+227,596
+541% +$535K 0.01% 2734
2023
Q3
$143K Sell
42,094
-142,404
-77% -$789K ﹤0.01% 3761
2023
Q2
$1.36M Buy
184,498
+75,921
+70% +$704K 0.02% 1598
2023
Q1
$1.12M Buy
108,577
+25,575
+31% +$309K 0.02% 1077
2022
Q4
$980K Buy
83,002
+77,571
+1,428% +$1.2M 0.02% 1015
2022
Q3
$114K Sell
5,431
-8,342
-61% -$232K ﹤0.01% 2371
2022
Q2
$428K Buy
+13,773
New +$470K 0.01% 1126
2021
Q3
Sell
-7,050
Closed -$444 1647
2021
Q2
$444 Buy
+7,050
New +$453K 0.02% 805
2018
Q3
$227K Buy
+3,445
New +$201K 0.13% 208

Other funds holding EBS